181 related articles for article (PubMed ID: 2494454)
1. Effect of intravenous streptokinase as compared with that of tissue plasminogen activator on left ventricular function after first myocardial infarction.
White HD; Rivers JT; Maslowski AH; Ormiston JA; Takayama M; Hart HH; Sharpe DN; Whitlock RM; Norris RM
N Engl J Med; 1989 Mar; 320(13):817-21. PubMed ID: 2494454
[TBL] [Abstract][Full Text] [Related]
2. The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction.
GUSTO Angiographic Investigators
N Engl J Med; 1993 Nov; 329(22):1615-22. PubMed ID: 8232430
[TBL] [Abstract][Full Text] [Related]
3. A difference between front-loaded streptokinase and standard-dose recombinant tissue-type plasminogen activator in preserving left ventricular function after acute myocardial infarction (the Central Illinois Thrombolytic Therapy Study).
Taylor GJ; Moses HW; Koester D; Colliver JA; Katholi RE; Dove JT; Woodruff RC; Mikell FL; Becker LC; Sheehan FH
Am J Cardiol; 1993 Nov; 72(14):1010-4. PubMed ID: 8213579
[TBL] [Abstract][Full Text] [Related]
4. Effect of intravenous streptokinase on left ventricular function and early survival after acute myocardial infarction.
White HD; Norris RM; Brown MA; Takayama M; Maslowski A; Bass NM; Ormiston JA; Whitlock T
N Engl J Med; 1987 Oct; 317(14):850-5. PubMed ID: 2888018
[TBL] [Abstract][Full Text] [Related]
5. A prospective, randomized trial comparing combination half-dose tissue-type plasminogen activator and streptokinase with full-dose tissue-type plasminogen activator. Kentucky Acute Myocardial Infarction Trial (KAMIT) Group.
Grines CL; Nissen SE; Booth DC; Gurley JC; Chelliah N; Wolf R; Blankenship J; Branco MC; Bennett K; DeMaria AN
Circulation; 1991 Aug; 84(2):540-9. PubMed ID: 1907228
[TBL] [Abstract][Full Text] [Related]
6. Plasminogen Activator Italian Multicenter Study (PAIMS): comparison of intravenous recombinant single-chain human tissue-type plasminogen activator (rt-PA) with intravenous streptokinase in acute myocardial infarction.
Magnani B
J Am Coll Cardiol; 1989 Jan; 13(1):19-26. PubMed ID: 2491867
[TBL] [Abstract][Full Text] [Related]
7. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction.
GUSTO investigators
N Engl J Med; 1993 Sep; 329(10):673-82. PubMed ID: 8204123
[TBL] [Abstract][Full Text] [Related]
8. Quantitative radionuclide assessment of regional ventricular function after thrombolytic therapy for acute myocardial infarction: results of phase I Thrombolysis in Myocardial Infarction (TIMI) trial.
Wackers FJ; Terrin ML; Kayden DS; Knatterud G; Forman S; Braunwald E; Zaret BL
J Am Coll Cardiol; 1989 Apr; 13(5):998-1005. PubMed ID: 2494246
[TBL] [Abstract][Full Text] [Related]
9. A new thrombolytic regimen for acute myocardial infarction using combination half dose tissue-type plasminogen activator with full dose streptokinase: a pilot study. KAMIT Study Group.
Grines CL; Nissen SE; Booth DC; Branco MC; Gurley JC; Bennett KA; DeMaria AN
J Am Coll Cardiol; 1989 Sep; 14(3):573-80. PubMed ID: 2504797
[TBL] [Abstract][Full Text] [Related]
10. The effect of intravenous thrombolytic therapy on left ventricular function: a report on tissue-type plasminogen activator and streptokinase from the Thrombolysis in Myocardial Infarction (TIMI Phase I) trial.
Sheehan FH; Braunwald E; Canner P; Dodge HT; Gore J; Van Natta P; Passamani ER; Williams DO; Zaret B
Circulation; 1987 Apr; 75(4):817-29. PubMed ID: 3103950
[TBL] [Abstract][Full Text] [Related]
11. Comparative effects of APSAC and rt-PA on infarct size and left ventricular function in acute myocardial infarction. A multicenter randomized study.
Bassand JP; Cassagnes J; Machecourt J; Lusson JR; Anguenot T; Wolf JE; Maublant J; Bertrand B; Schiele F
Circulation; 1991 Sep; 84(3):1107-17. PubMed ID: 1909218
[TBL] [Abstract][Full Text] [Related]
12. New developments in thrombolytic therapy.
Collen D; Gold HK
Adv Exp Med Biol; 1990; 281():333-54. PubMed ID: 2129372
[TBL] [Abstract][Full Text] [Related]
13. Streptokinase and recombinant tissue plasminogen activator (rt-PA) are equally effective in treating acute myocardial infarction.
Sherry S; Marder VJ
Ann Intern Med; 1991 Mar; 114(5):417-23. PubMed ID: 1899546
[TBL] [Abstract][Full Text] [Related]
14. Thrombolysis with intravenous human recombinant tissue-type plasminogen activator in acute myocardial infarction: the European experience.
de Bono DP
J Am Coll Cardiol; 1987 Nov; 10(5 Suppl B):75B-78B. PubMed ID: 2959717
[TBL] [Abstract][Full Text] [Related]
15. Intravenous tissue plasminogen activator and size of infarct, left ventricular function, and survival in acute myocardial infarction.
Van de Werf F; Arnold AE
BMJ; 1988 Nov; 297(6660):1374-9. PubMed ID: 3146370
[TBL] [Abstract][Full Text] [Related]
16. Reperfusion therapy in inferior myocardial infarction.
Bates ER
J Am Coll Cardiol; 1988 Dec; 12(6 Suppl A):44A-51A. PubMed ID: 3142944
[TBL] [Abstract][Full Text] [Related]
17. Heart rate variability assessment early after acute myocardial infarction. Pathophysiological and prognostic correlates. GUSTO ECG Substudy Investigators. Global Utilization of Streptokinase and TPA for Occluded Arteries.
Singh N; Mironov D; Armstrong PW; Ross AM; Langer A
Circulation; 1996 Apr; 93(7):1388-95. PubMed ID: 8641028
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the effects of streptokinase and tissue plasminogen activator on regional wall motion after first myocardial infarction: analysis by the centerline method with correction for area at risk.
Cross DB; Ashton NG; Norris RM; White HD
J Am Coll Cardiol; 1991 Apr; 17(5):1039-46. PubMed ID: 1901072
[TBL] [Abstract][Full Text] [Related]
19. Anistreplase versus alteplase in acute myocardial infarction: comparative effects on left ventricular function, morbidity and 1-day coronary artery patency. The TEAM-3 Investigators.
Anderson JL; Becker LC; Sorensen SG; Karagounis LA; Browne KF; Shah PK; Morris DC; Fintel DJ; Mueller HS; Ross AM
J Am Coll Cardiol; 1992 Oct; 20(4):753-66. PubMed ID: 1527286
[TBL] [Abstract][Full Text] [Related]
20. Is survival in acute myocardial infarction related to thrombolytic efficacy or the open-artery hypothesis? A controversy to be investigated with GUSTO.
Bates ER
Chest; 1992 Apr; 101(4 Suppl):140S-150S. PubMed ID: 1555479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
